Zhang Jie
Zhang Jie — Chief Physician — Thoracic Surgery — Shanghai Chest Hospital
Specialties
Comprehensive treatment and minimally invasive radical surgery for lung cancer, esophageal cancer, mediastinal tumors, and soft tissue tumors, one of the few thoracic surgeons in China proficient in all "four scopes" (thoracoscope, laparoscope, esophagoscope, bronchoscope), licensed physician in Pennsylvania, USA (MD466060). 1. Minimally invasive surgery following international standards, specialized in the diagnosis and treatment of small lung nodules; performing a variety of thoracic minimally invasive surgeries including thoracoscopy, mediastinoscopy, and muscle-preserving procedures, with emphasis on preserving and reconstructing patient function. 2. Minimally invasive treatment of the esophagus: specializing in endoscopic surgical treatment, including endoscopic EMR/ESD standard resection, percutaneous endoscopic gastrostomy (PEG), esophageal dilation, cryotherapy, radiofrequency ablation, esophageal stenting, laparoscopic gastrojejunostomy, and total endoscopic radical surgery for esophageal cancer. 3. Surgical treatment of benign esophageal diseases, including achalasia, hiatal hernia, and gastroesophageal reflux disease.
Education
Medical Doctor, obtained a PhD from Fudan University in 2005, and completed postdoctoral research (while employed) at Shanghai Jiao Tong University Chest Hospital in 2008
Professional Experience
Zhang Jie, male, is currently the chief thoracic surgeon at Shanghai Chest Hospital, deputy director of the sub-department, and director of the Esophagoscopy Room. He was selected for the Ministry of Education New Century Talent Program, Shanghai Pujiang Talent Program, Shanghai New Long March Commando, a recipient of Fudan University's “Excellence Program”, and a key young talent in the Shanghai health system (New Outstanding Youth). He has long been engaged in radical surgery for lung cancer, esophageal cancer, cardia cancer, mediastinal tumors, and soft tissue tumors, as well as surgical treatment for achalasia, hiatal hernia, and gastroesophageal reflux disease. He currently specializes in endoscopic minimally invasive surgery and endoscopic surgical treatment. In 2003, he studied for nearly two years at the Fred Hutchinson Cancer Center and the University of Washington in the United States. During his postdoctoral period in 2008, he received guidance from lung cancer experts Professor Liao Meilin and Professor Luo Qingquan. In 2009, he completed a one-year clinical fellow training in thoracic surgery at the University of Pittsburgh Medical Center, obtained the medical license and prescription rights there, and in 2018 obtained the unrestricted medical practice license in the United States (MD466060), providing treatment for a large number of patients in China and the United States. As a graduate supervisor, he has supervised or co-supervised multiple graduate students. He has received the Science and Technology Award of the Chinese Anti-Cancer Association, the Shanghai Science and Technology Progress Award, the Shanghai Excellent Invention Award, the Meiji Life Science Award of Shanghai (Excellence Award), and the Shanghai Medical Science and Technology Award, among others.